Malignant mesothelioma in south east England: Clinicopathological experience of 272 cases

Thorax

Volumn 52, Issue 6, 1997, Pages 507-512

  Yates, D H ^a,c   Corrin, B ^b   Stidolph, P N ^a   Browne, K ^a  

^a Med Boarding Ctr for Resp Dis   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; DYSPNEA; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PLEURA EFFUSION; PRIORITY JOURNAL; THORAX PAIN; UNITED KINGDOM;

EID: 0030856483     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.6.507     Document Type: Article

References (20)

1. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancer 1995; 345:535-9.
2. Roberts GH. Diffuse pleural mesothelioma. A clinical and pathological study. Br J Dis Chest 1970;64:201-11.
3. Elmes PC, Simpson MJ. The clinical aspects of mesothelioma. Q J Med 1976;45:427-49.
4. Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff I. Malignant mesothelioma in a cohort of asbestos workers: clinical presentation, diagnosis and causes of death. Br J Ind Med 1988;45:182-7.
5. National Insurance (Industrial Injuries) (Prescribed Diseases) Regulations 1966.
6. Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure and malignant mesothelioma. Cancer Res 1991;51: 2263-7.
7. Hirsch A, Brochard P, de Cremoux H, et al. Features of asbestos-exposed and unexposed mesothelioma. Am J Ind Med 1982;3:413-22.
8. Peto J, Henderson BE, Pike MC. Trends in mesothelioma incidence in the United States. In: Banbury Report 9: quantification of occupational cancer. New York: Cold Spring Harbor Laboratory, 1981:51-72.
9. Law MR, Ward FG, Hodson M, Heard BE. Evidence for longer survival of patients with pleural mesothelioma without asbestos exposure. Thorax 1983;38:744-6.
10. McDonald AD, Magner D, Eyssen G. Primary malignant mesothelial tumors in Canada, 1960-1968. Cancer 1973; 31:869-76.
11. Wright WE, Sherwin RS, Dickson CA, Bernstein L, et al. Malignant mesothelioma: incidence, asbestos exposure, and reclassification of histopathology. Br J Ind Med 1984; 41:39-45.
12. Whitwell F, Rawcliffe RM. Diffuse malignant mesothelioma and asbestos exposure. Thorax 1971;26:6-22.
13. Spirtas R, Heineman EF, Bernstein L. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994;51:804-11.
14. Lanphear BP, Buncher RC. Latent period for malignant mesothelioma of occupational origin. J Occup Med 1992; 34:718-21.
15. Browne K, Smither WJ. Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites. Br J Ind Med 1983;40:145-52.
16. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983;77:321-43.
17. Knappman J. Observations on 251 necropsied cases of mesothelioma in Hamburg 1958-68. Dissertation, Hamburg (Germany), 1971.
18. Boutin C, Rey F, Gouvernet J. Malignant mesothelioma: prognostic factors in a series of 125 patients studied from 1973 to 1987. Bull Acad Natl Med 1992;176:105-14.
19. Dorward AJ, Stack BH. Diffuse malignant pleural mesothelioma in Glasgow. Br J Dis Chest 1981;75:397-402.
20. Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax 1982;37:810-5.